2601 - 2650 of 8571 Results
Title
Year
-
RESTRICTEDTitle: MRI biomarkers of motor and non-motor symptoms in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 73Issue #:Start Page: 85End Page: 93Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145760Citation Count: 42
-
RESTRICTEDTitle: Therapeutic antisense oligonucleotides for movement disordersJournal Name: Medicinal Research ReviewsPublisher: WileyVol: 41Issue #: 5Start Page: 2656End Page: 2688Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/med.21706Citation Count: 17
-
OPENTitle: Artificial Intelligence in MedicineJournal Name: Lecture Notes in Computer SciencePublisher: Springer International PublishingVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-3-030-77211-6Best OA location URL: https://link.springer.com/content/pdf/bfm:978-3-030-77211-6/1?pdf=chapter%20tocCitation Count:
-
RESTRICTEDTitle: Magnetic resonance imaging quality control, quality assurance and quality improvementJournal Name: Pediatric RadiologyPublisher: Springer Science and Business Media LLCVol: 51Issue #: 5Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00247-021-05043-6Citation Count: 8
-
RESTRICTEDTitle: Initiation and progression of α-synuclein pathology in Parkinson’s diseaseJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 79Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00018-022-04240-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00018-022-04240-2.pdfCitation Count: 35
- Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk2021RESTRICTEDTitle: Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease RiskJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 815End Page: 831Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28475Citation Count: 14
-
RESTRICTEDTitle: Genotype–Phenotype Relations for the Atypical Parkinsonism Genes: MDSGene Systematic ReviewJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1499End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28517Best OA location URL: https://mediatum.ub.tum.de/doc/1654707/document.pdfCitation Count: 24
- Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis2021RESTRICTEDTitle: Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1293End Page: 1307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28599Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/238481/238481.pdfCitation Count: 20
-
RESTRICTEDTitle: Dopamine Receptors in Parkinson's Disease: A Meta‐Analysis of Imaging StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1781End Page: 1791Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28632Citation Count: 43
-
RESTRICTEDTitle: The Gastrointestinal Dysfunction Scale for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2358End Page: 2366Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28675Citation Count: 14
-
RESTRICTEDTitle: On‐Demand Therapy for OFF Episodes in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2244End Page: 2253Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28726Citation Count: 18
- Genotype–Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene Review2021RESTRICTEDTitle: Genotype–Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene ReviewJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2468End Page: 2480Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28753Citation Count: 37
- Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms2021RESTRICTEDTitle: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s SymptomsJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 19Issue #: 1Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph19010364Best OA location URL: https://www.mdpi.com/1660-4601/19/1/364/pdf?version=1641285359Citation Count: 27
-
RESTRICTEDTitle: Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 ParkinsonismJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 3Start Page: 1045End Page: 1045Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22031045Best OA location URL: https://www.mdpi.com/1422-0067/22/3/1045/pdf?version=1611717845Citation Count: 16
- Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade2022RESTRICTEDTitle: Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last DecadeJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 1426End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13081426Best OA location URL: https://www.mdpi.com/2073-4425/13/8/1426/pdf?version=1660204965Citation Count: 5
-
RESTRICTEDTitle: Therapeutic Advances in Diabetes, Autoimmune, and Neurological DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 6Start Page: 2805End Page: 2805Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22062805Best OA location URL: https://www.mdpi.com/1422-0067/22/6/2805/pdf?version=1615774433Citation Count: 8
-
RESTRICTEDTitle: Emerging hiPSC Models for Drug Discovery in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 15Start Page: 8196End Page: 8196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22158196Best OA location URL: https://www.mdpi.com/1422-0067/22/15/8196/pdf?version=1627640850Citation Count: 11
-
RESTRICTEDTitle: Neurons and Glia Interplay in α-SynucleinopathiesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 9Start Page: 4994End Page: 4994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22094994Best OA location URL: https://www.mdpi.com/1422-0067/22/9/4994/pdf?version=1620472084Citation Count: 31
-
RESTRICTEDTitle: Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological DisordersJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 9Start Page: 4536End Page: 4536Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22094536Best OA location URL: https://www.mdpi.com/1422-0067/22/9/4536/pdfCitation Count: 11
-
RESTRICTEDTitle: Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 14Start Page: 4966End Page: 4966Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21144966Best OA location URL: https://www.mdpi.com/1422-0067/21/14/4966/pdf?version=1594721931Citation Count: 23
- Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings2019RESTRICTEDTitle: Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting ProceedingsJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0476-1Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0476-1Citation Count: 9
-
RESTRICTEDTitle: Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and ShadowsJournal Name: CellsPublisher: MDPI AGVol: 8Issue #: 11Start Page: 1317End Page: 1317Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells8111317Best OA location URL: https://www.mdpi.com/2073-4409/8/11/1317/pdf?version=1571996609Citation Count: 23
-
RESTRICTEDTitle: Protein misfolding in neurodegenerative diseases: implications and strategiesJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-017-0077-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-017-0077-5Citation Count: 428
- Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry2023RESTRICTEDTitle: Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass SpectrometryJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 22Issue #: 8Start Page: 100608End Page: 100608Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mcpro.2023.100608Best OA location URL: http://www.mcponline.org/article/S1535947623001196/pdfCitation Count: 8
-
RESTRICTEDTitle: PAKs in the brain: Function and dysfunctionJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1864Issue #: 2Start Page: 444End Page: 453Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2017.11.005Best OA location URL: https://doi.org/10.1016/j.bbadis.2017.11.005Citation Count: 40
-
RESTRICTEDTitle: Review: Somatic mutations in neurodegenerationJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 44Issue #: 3Start Page: 267End Page: 285Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12465Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12465Citation Count: 73
- Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid2023RESTRICTEDTitle: Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluidJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 1179End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41596-022-00787-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561622Citation Count: 35
- Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options2018RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseasesJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1237End Page: 1245Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=renderCitation Count: 42
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action2016RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246
-
RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 53
-
RESTRICTEDTitle: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 21End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016Citation Count: 16
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5
-
RESTRICTEDTitle: Small Molecules to Improve ER Proteostasis in DiseaseJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 40Issue #: 9Start Page: 684End Page: 695Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.tips.2019.07.003Best OA location URL: http://manuscript.elsevier.com/S0165614719301403/pdf/S0165614719301403.pdfCitation Count: 63
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
- Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s2014RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1
- Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”2023RESTRICTEDTitle: Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”Journal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 13824End Page: 13824Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acsami.3c02300Best OA location URL: https://doi.org/10.1021/acsami.3c02300Citation Count: 0
-
RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name: British Journal of PharmacologyPublisher: WileyVol: 180Issue #: 13Start Page: 1651End Page: 1673Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.16078Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16078Citation Count: 7
-
RESTRICTEDTitle: Huntington disease: A quarter century of progress since the gene discoveryJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 396Issue #:Start Page: 52End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.09.022Citation Count: 59
-
RESTRICTEDTitle: REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.7916/d84b2zdfCitation Count: 4
-
RESTRICTEDTitle: Juvenile parkinsonism: Differential diagnosis, genetics, and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 74End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.025Citation Count: 67
- Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics2011RESTRICTEDTitle: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 39End Page: 52Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-011-0682-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdfCitation Count: 68
-
RESTRICTEDTitle: Digital technologies: Innovations that transform the face of drug developmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 16Issue #: 8Start Page: 1323End Page: 1330Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13533Citation Count: 2
-
RESTRICTEDTitle: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an UpdateJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 5Start Page: 973End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440Citation Count: 34
-
RESTRICTEDTitle: Unmet needs in Parkinson disease: Motor and non-motorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S7End Page: S12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802020307380/pdfCitation Count: 60
- Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.2021RESTRICTEDTitle: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326Citation Count: 7
-
RESTRICTEDTitle: γ‐Synuclein and the progression of cancerJournal Name: The FASEB JournalPublisher: WileyVol: 21Issue #: 13Start Page: 3419End Page: 3430Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.07-8379revCitation Count: 91
-
RESTRICTEDTitle: Clinical and Imaging Markers of Prodromal Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00395Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00395/pdfCitation Count: 91
-
RESTRICTEDTitle: Biomarkers for cognitive dysfunction in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 46Issue #:Start Page: S19End Page: S23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.023Citation Count: 36
-
RESTRICTEDTitle: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 36Issue #:Start Page: 20End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003Citation Count: 33